Syringe distribution to injection drug users for prevention of HIV infection: Opinions and practices of health care providers in New York City

被引:7
作者
Coffin, PO
Fuller, C
Blaney, S
Vadnai, L
Miller, S
Vlahov, D
机构
[1] New York Acad Med, Ctr Urban Epidemiol Studies, New York, NY USA
[2] Columbia Univ, Ctr Infect Dis Epidemiol Res, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA
[3] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA
关键词
D O I
10.1086/381095
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Expanded Syringe Access Demonstration Program ( ESAP), which was intended to increase access to syringes for injection drug users (IDUs), went into effect in New York State on 1 January 2001. ESAP allowed prescription-authorized health care providers to register to distribute syringes without a prescription. In spring 2002, we conducted a random postal survey of 1100 providers in New York City to evaluate involvement in ESAP and willingness to furnish IDUs with syringes. Among 363 nurse practitioners, physicians, and physician assistants responding, 16.9% knew about ESAP, and 2.0% believed they were registered; 50.5% would consider distributing syringes to patients who were IDUs. Most of those unwilling to distribute syringes were concerned about legal and moral issues. More respondents agreed that providers should prescribe syringes than distribute syringes (41.1% vs. 22.7%; P < .0001). These results suggest that many providers are willing to furnish IDUs with syringes but are unaware of the current law.
引用
收藏
页码:438 / 441
页数:4
相关论文
共 18 条
[1]  
[Anonymous], 1993, The public health impact of needle exchange programs in the United States and abroad
[2]  
Burris Scott, 2002, J Am Pharm Assoc (Wash), V42, pS13
[3]   Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City [J].
Des Jarlais, DC ;
Diaz, T ;
Perlis, T ;
Vlahov, D ;
Maslow, C ;
Latka, M ;
Rockwell, R ;
Edwards, V ;
Friedman, SR ;
Monterroso, E ;
Williams, I ;
Garfein, RS .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (05) :467-471
[4]   HIV incidence among injection drug users in New York City, 1992-1997: Evidence for a declining epidemic [J].
Des Jarlais, DC ;
Marmor, M ;
Friedmann, P ;
Titus, S ;
Aviles, E ;
Deren, S ;
Torian, L ;
Glebatis, D ;
Murrill, C ;
Monterroso, E ;
Friedman, SR .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2000, 90 (03) :352-359
[5]  
Fuller Crystal M, 2002, J Am Pharm Assoc (Wash), V42, pS77, DOI 10.1331/1086-5802.42.0.S77.Fuller
[6]   The estimated prevalence and incidence of HIV in 96 large US metropolitan areas [J].
Holmberg, SD .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1996, 86 (05) :642-654
[7]   HIV incidence among injecting drug users in New York City syringe-exchange programmes [J].
Jarlais, DCD ;
Marmor, M ;
Paone, D ;
Titus, S ;
Shi, QH ;
Perlis, T ;
Jose, B ;
Friedman, SR .
LANCET, 1996, 348 (9033) :987-991
[8]  
Klein Susan J, 2002, J Am Pharm Assoc (Wash), V42, pS28, DOI 10.1331/1086-5802.42.0.S28.Klein
[9]  
Klein Susan J, 2002, J Am Pharm Assoc (Wash), V42, pS105, DOI 10.1331/1086-5802.42.0.S105.Klein
[10]   Multiple access to sterile syringes for injection drug users: Vending machines, needle exchange programs and legal pharmacy sales in Marseille, France [J].
Moatti, JP ;
Vlahov, D ;
Feroni, I ;
Perrin, V ;
Obadia, Y .
EUROPEAN ADDICTION RESEARCH, 2001, 7 (01) :40-45